Contributors
PVL
BT analysed the data, interpreted the results with input from HPT, VTTD, HS-V, CN, PVL, MLN, CS, TVN, and KM, and wrote the first draft of the manuscript with input from HS-V. HPT, KB, TLP, NTT, DYU, and LTTV were involved in the establishment, day-to-day management, and implementation of the trial. VTTD was responsible for the laboratory work at Pasteur with PTH, TVP, and HNLT, with oversight from HS-V, JB, AB, BDO, CS, and PVL. CS oversaw the microbiology work at the Murdoch Children's Research Institute, which was managed by BDO with input from MLN and JH. MLN performed the density analyses. RAH and LS were responsible for the immunology work at the Murdoch Children's Research Institute with oversight from PVL and AB. CN advised on the sample size and statistical analyses. TVN was involved in the design and establishment and had overall responsibility for the conduct of the trial in Viet Nam as site principal investigator. KM conceived the study and had overall responsibility for all aspects of the trial as the principal investigator and was responsible for the decision to submit the manuscript for publication. All data were accessed and verified by BT, clinical data by KB, and laboratory data by VTTD, RAH, MLN, and JB. All authors contributed to refinement of and approved the submitted manuscript.